Top Markets
Coin of the day
ERYTECH Pharma S.A. ERYTECH Pharma S.A.

ERYTECH Pharma S.A.

ERYP
Classement en actions #24699
ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on... ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on creating innovative therapies derived from red blood cells. These treatments target various types of cancer and rare (orphan) diseases, with the company operating in both France and the United States. Its primary experimental drug, eryaspase, is currently undergoing Phase 3 clinical trials for patients battling second-line pancreatic cancer. Furthermore, this candidate is also in Phase 2 development for triple-negative breast cancer and for individuals with second-line acute lymphoblastic leukemia. The company is additionally advancing erymethionase, a preclinical-stage product. This candidate utilizes methionine-gamma-lyase, encased within red blood cells, to specifically address cancers that are dependent on methionine for growth. Established in 2004, ERYTECH Pharma's corporate headquarters are situated in Lyon, France.
Prix de l'action
$0.95011029
Dernière synchronisation: 2023-06-28
Capitalisation boursière
$57.72M
Changement (1 jour)
8.53%
Changement (1 an)
0.00%
Pays
FR
Échange ERYTECH Pharma S.A. (ERYP)

Catégorie

Historique du prix de l'action pour ERYTECH Pharma S.A. (ERYP)
Prix de clôture le plus élevé : $0.90 le 2023-06-01

Prix de clôture le plus bas : $14.08 le 2013-05-01
Historique du prix de l'action de ERYTECH Pharma S.A. de 2013 à 2026
Performance annuelle du prix de l'action
Année Performance
2023 73.43%
2022 -78.67%
2021 -73.09%
2020 82.31%
2019 -31.19%
2018 -67.04%
2017 59.44%
2016 -51.05%
2015 -15.86%
2014 158.90%
2013 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$551.23 38.69%
US
$1.06K 59.04%
NL
$146.66 459.34%
US
$118.70 -18.24%
AU
$770.19 9.84%
CH